speb/financial-data huggingface dataset:
PRCT balance_sheet (annual, 2021-12-31) — Other Inventories: 830000.00
PRCT cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 84710000.00
PRCT balance_sheet (annual, 2021-12-31) — Prepaid Assets: 2586000.00
PRCT cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
PRCT balance_sheet (annual, 2021-12-31) — Restricted Cash: 0.00
PRCT income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
PRCT income_statement (annual, 2021-12-31) — Total Unusual Items: 199000.00
PRCT income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 199000.00
PRCT income_statement (annual, 2022-12-31) — +Operating Expense: 117809000.00
PRCT income_statement (annual, 2022-12-31) — +Total Revenue: 75014000.00
PRCT balance_sheet (annual, 2022-12-31) — Accounts Payable: 9391000.00
PRCT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 15272000.00
PRCT balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -9004000.00
PRCT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 545753000.00
PRCT cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 62000.00
PRCT income_statement (annual, 2022-12-31) — Basic Average Shares: 44400000.00
PRCT income_statement (annual, 2022-12-31) — Basic EPS: -1.96
PRCT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 305097000.00
PRCT cash_flow (annual, 2022-12-31) — Capital Expenditure: -2653000.00
PRCT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 26104000.00
PRCT balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
PRCT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 221859000.00
PRCT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 221859000.00
PRCT balance_sheet (annual, 2022-12-31) — Cash Equivalents: 212989000.00
PRCT balance_sheet (annual, 2022-12-31) — Cash Financial: 8870000.00
PRCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 3612000.00
PRCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2653000.00
PRCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -80382000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Account Payable: 3959000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 7729000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Interest Payable: 757000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Inventory: -15251000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -51000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 2986000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 1830000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Payable: 3959000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 11688000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1880000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Receivables: -10809000.00
PRCT cash_flow (annual, 2022-12-31) — Change In Working Capital: -11487000.00
PRCT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -10809000.00
PRCT cash_flow (annual, 2022-12-31) — Changes In Cash: -79423000.00
PRCT balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
PRCT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 197072000.00
PRCT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
PRCT balance_sheet (annual, 2022-12-31) — Construction In Progress: 5671000.00
PRCT income_statement (annual, 2022-12-31) — Cost Of Revenue: 37929000.00
PRCT balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 2538000.00
PRCT balance_sheet (annual, 2022-12-31) — Current Assets: 272626000.00
PRCT balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 2129000.00
PRCT balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2129000.00
PRCT balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 2855000.00
PRCT balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 2855000.00
PRCT balance_sheet (annual, 2022-12-31) — Current Liabilities: 35290000.00
PRCT balance_sheet (annual, 2022-12-31) — Current Provisions: 200000.00
PRCT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2841000.00
PRCT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2841000.00
PRCT balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 1779000.00
PRCT income_statement (annual, 2022-12-31) — Diluted Average Shares: 44400000.00
PRCT income_statement (annual, 2022-12-31) — Diluted EPS: -1.96
PRCT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -87154000.00
PRCT income_statement (annual, 2022-12-31) — EBIT: -81971000.00
PRCT income_statement (annual, 2022-12-31) — EBITDA: -79130000.00
PRCT cash_flow (annual, 2022-12-31) — End Cash Position: 225674000.00
PRCT cash_flow (annual, 2022-12-31) — Financing Cash Flow: 3612000.00
PRCT balance_sheet (annual, 2022-12-31) — Finished Goods: 14388000.00
PRCT cash_flow (annual, 2022-12-31) — Free Cash Flow: -83035000.00
PRCT cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 283000.00
PRCT income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -283000.00
PRCT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -6000.00
PRCT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1477000.00
PRCT balance_sheet (annual, 2022-12-31) — Gross PPE: 41141000.00
PRCT income_statement (annual, 2022-12-31) — Gross Profit: 37085000.00
PRCT income_statement (annual, 2022-12-31) — Interest Expense: 5183000.00
PRCT income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 5183000.00
PRCT income_statement (annual, 2022-12-31) — Interest Income: 2497000.00
PRCT income_statement (annual, 2022-12-31) — Interest Income Non Operating: 2497000.00
PRCT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 4291000.00
PRCT balance_sheet (annual, 2022-12-31) — Interest Payable: 532000.00
PRCT balance_sheet (annual, 2022-12-31) — Inventory: 28543000.00
PRCT balance_sheet (annual, 2022-12-31) — Invested Capital: 248285000.00
PRCT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2653000.00
PRCT cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
PRCT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 51195000.00
PRCT balance_sheet (annual, 2022-12-31) — Leases: 4941000.00
PRCT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 23975000.00
PRCT balance_sheet (annual, 2022-12-31) — Long Term Debt: 51213000.00
PRCT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 75188000.00
PRCT cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 51195000.00
PRCT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -50000000.00
PRCT balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3260000.00
PRCT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
PRCT income_statement (annual, 2022-12-31) — Net Income: -87154000.00
PRCT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -87154000.00
PRCT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -87154000.00
PRCT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -87154000.00
PRCT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -87154000.00
PRCT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -87154000.00
PRCT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -87154000.00
PRCT income_statement (annual, 2022-12-31) — Net Interest Income: -2686000.00
PRCT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1195000.00
PRCT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1195000.00
PRCT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2686000.00
PRCT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -4000000.00
PRCT balance_sheet (annual, 2022-12-31) — Net PPE: 32137000.00
PRCT cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2653000.00
PRCT cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
PRCT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 195595000.00
PRCT income_statement (annual, 2022-12-31) — Normalized EBITDA: -75589000.00
PRCT income_statement (annual, 2022-12-31) — Normalized Income: -83613000.00
PRCT cash_flow (annual, 2022-12-31) — Operating Cash Flow: -80382000.00
PRCT cash_flow (annual, 2022-12-31) — Operating Gains Losses: 3541000.00
PRCT income_statement (annual, 2022-12-31) — Operating Income: -80724000.00
PRCT income_statement (annual, 2022-12-31) — Operating Revenue: 75014000.00
PRCT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 44828000.00
PRCT balance_sheet (annual, 2022-12-31) — Other Current Assets: 6175000.00
PRCT balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 3901000.00
PRCT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -6000.00
PRCT income_statement (annual, 2022-12-31) — Other Income Expense: -3744000.00
PRCT cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1478000.00
PRCT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 3089000.00
PRCT income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -203000.00
PRCT balance_sheet (annual, 2022-12-31) — Other Properties: 27269000.00
PRCT income_statement (annual, 2022-12-31) — Other Special Charges: 3258000.00
PRCT balance_sheet (annual, 2022-12-31) — Payables: 10220000.00
PRCT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 12758000.00
PRCT balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 13447000.00
PRCT balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
PRCT cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
PRCT income_statement (annual, 2022-12-31) — Pretax Income: -87154000.00
PRCT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 6417000.00
PRCT balance_sheet (annual, 2022-12-31) — Properties: 0.00
PRCT cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 0.00
PRCT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2653000.00
PRCT balance_sheet (annual, 2022-12-31) — Raw Materials: 12417000.00
PRCT balance_sheet (annual, 2022-12-31) — Receivables: 15272000.00
PRCT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 37929000.00
PRCT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2841000.00
PRCT cash_flow (annual, 2022-12-31) — Repayment Of Debt: -50000000.00
PRCT income_statement (annual, 2022-12-31) — Research And Development: 28981000.00
PRCT balance_sheet (annual, 2022-12-31) — Restricted Cash: 777000.00
PRCT balance_sheet (annual, 2022-12-31) — Retained Earnings: -348675000.00
PRCT income_statement (annual, 2022-12-31) — Selling General And Administration: 88828000.00
PRCT balance_sheet (annual, 2022-12-31) — Share Issued: 44828000.00
PRCT income_statement (annual, 2022-12-31) — Special Income Charges: -3258000.00
PRCT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 10337000.00
PRCT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 197072000.00
PRCT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 195595000.00
PRCT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
PRCT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
PRCT balance_sheet (annual, 2022-12-31) — Total Assets: 309329000.00
PRCT balance_sheet (annual, 2022-12-31) — Total Capitalization: 248285000.00
PRCT balance_sheet (annual, 2022-12-31) — Total Debt: 77317000.00
PRCT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 197072000.00
PRCT income_statement (annual, 2022-12-31) — Total Expenses: 155738000.00
PRCT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 112257000.00
PRCT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 36703000.00
PRCT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 76967000.00
PRCT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -80724000.00
PRCT balance_sheet (annual, 2022-12-31) — Total Tax Payable: 829000.00
PRCT income_statement (annual, 2022-12-31) — Total Unusual Items: -3541000.00
PRCT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -3541000.00
PRCT balance_sheet (annual, 2022-12-31) — Work In Process: 1738000.00
PRCT balance_sheet (annual, 2022-12-31) — Working Capital: 237336000.00
PRCT income_statement (annual, 2023-12-31) — +Operating Expense: 180219000.00
PRCT income_statement (annual, 2023-12-31) — +Total Revenue: 136191000.00
PRCT balance_sheet (annual, 2023-12-31) — Accounts Payable: 13499000.00
PRCT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 48376000.00
PRCT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -3669000.00
PRCT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 735240000.00
PRCT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 995000.00
PRCT income_statement (annual, 2023-12-31) — Basic Average Shares: 47255000.00
PRCT income_statement (annual, 2023-12-31) — Basic EPS: -2.24
PRCT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 225674000.00
PRCT cash_flow (annual, 2023-12-31) — Capital Expenditure: -25206000.00
PRCT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 27865000.00
PRCT balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
PRCT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 257222000.00
PRCT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 257222000.00
PRCT balance_sheet (annual, 2023-12-31) — Cash Equivalents: 250613000.00
PRCT balance_sheet (annual, 2023-12-31) — Cash Financial: 6609000.00
PRCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 167795000.00
PRCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -25206000.00
PRCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -108003000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Account Payable: 5789000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 3563000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Interest Payable: 125000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Inventory: -9751000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -868000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -1149000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 8306000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Payable: 5789000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 9352000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 1051000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Receivables: -33103000.00
PRCT cash_flow (annual, 2023-12-31) — Change In Working Capital: -26162000.00
PRCT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -33103000.00
PRCT cash_flow (annual, 2023-12-31) — Changes In Cash: 34586000.00
PRCT balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
PRCT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 280752000.00
PRCT cash_flow (annual, 2023-12-31) — Common Stock Issuance: 161705000.00
PRCT balance_sheet (annual, 2023-12-31) — Construction In Progress: 3548000.00
PRCT income_statement (annual, 2023-12-31) — Cost Of Revenue: 65142000.00
PRCT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 439000.00
PRCT balance_sheet (annual, 2023-12-31) — Current Assets: 350567000.00
PRCT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1683000.00
PRCT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1683000.00
PRCT balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 5656000.00
PRCT balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 5656000.00
PRCT balance_sheet (annual, 2023-12-31) — Current Liabilities: 45927000.00
PRCT balance_sheet (annual, 2023-12-31) — Current Provisions: 232000.00
PRCT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 3807000.00
PRCT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 3807000.00
PRCT balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 0.00
PRCT income_statement (annual, 2023-12-31) — Diluted Average Shares: 47255000.00
PRCT income_statement (annual, 2023-12-31) — Diluted EPS: -2.24
PRCT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -105897000.00
PRCT income_statement (annual, 2023-12-31) — EBIT: -101822000.00
PRCT income_statement (annual, 2023-12-31) — EBITDA: -98015000.00
PRCT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
PRCT cash_flow (annual, 2023-12-31) — End Cash Position: 260260000.00
PRCT cash_flow (annual, 2023-12-31) — Financing Cash Flow: 167795000.00
PRCT balance_sheet (annual, 2023-12-31) — Finished Goods: 21877000.00
PRCT cash_flow (annual, 2023-12-31) — Free Cash Flow: -133209000.00
PRCT cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 107000.00
PRCT income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -107000.00
PRCT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 84000.00
PRCT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1204000.00
PRCT balance_sheet (annual, 2023-12-31) — Gross PPE: 52658000.00
PRCT income_statement (annual, 2023-12-31) — Gross Profit: 71049000.00
PRCT income_statement (annual, 2023-12-31) — Interest Expense: 3995000.00
PRCT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3995000.00
PRCT income_statement (annual, 2023-12-31) — Interest Income: 7551000.00
PRCT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 7551000.00
PRCT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 4056000.00
PRCT balance_sheet (annual, 2023-12-31) — Interest Payable: 333000.00
PRCT balance_sheet (annual, 2023-12-31) — Inventory: 39756000.00
PRCT balance_sheet (annual, 2023-12-31) — Invested Capital: 332091000.00
PRCT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -25206000.00
PRCT cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 161705000.00
PRCT cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
PRCT balance_sheet (annual, 2023-12-31) — Leases: 12362000.00
PRCT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 26182000.00
PRCT balance_sheet (annual, 2023-12-31) — Long Term Debt: 51339000.00
PRCT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 77521000.00
PRCT cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
PRCT cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
PRCT balance_sheet (annual, 2023-12-31) — Long Term Provisions: 517000.00
PRCT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 14379000.00
PRCT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 161705000.00
PRCT cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PRCT income_statement (annual, 2023-12-31) — Net Income: -105897000.00
PRCT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -105897000.00
PRCT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -105897000.00
PRCT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -105897000.00
PRCT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -105897000.00
PRCT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -105897000.00
PRCT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -105897000.00
PRCT income_statement (annual, 2023-12-31) — Net Interest Income: 3556000.00
PRCT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
PRCT cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
PRCT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 3556000.00
PRCT balance_sheet (annual, 2023-12-31) — Net PPE: 48989000.00
PRCT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -25206000.00
PRCT cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
PRCT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 279548000.00
PRCT income_statement (annual, 2023-12-31) — Normalized EBITDA: -97908000.00
PRCT income_statement (annual, 2023-12-31) — Normalized Income: -105790000.00
PRCT cash_flow (annual, 2023-12-31) — Operating Cash Flow: -108003000.00
PRCT cash_flow (annual, 2023-12-31) — Operating Gains Losses: 107000.00
PRCT income_statement (annual, 2023-12-31) — Operating Income: -109170000.00
PRCT income_statement (annual, 2023-12-31) — Operating Revenue: 136191000.00
PRCT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 50771000.00
PRCT balance_sheet (annual, 2023-12-31) — Other Current Assets: 5213000.00
PRCT balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 5808000.00
PRCT balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 84000.00
PRCT income_statement (annual, 2023-12-31) — Other Income Expense: -203000.00
PRCT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1204000.00
PRCT cash_flow (annual, 2023-12-31) — Other Non Cash Items: 13000.00
PRCT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 3957000.00
PRCT balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 517000.00
PRCT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -96000.00
PRCT balance_sheet (annual, 2023-12-31) — Other Properties: 22369000.00
PRCT balance_sheet (annual, 2023-12-31) — Payables: 15224000.00
PRCT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 15663000.00
PRCT balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 16885000.00
PRCT balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
PRCT cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
PRCT income_statement (annual, 2023-12-31) — Pretax Income: -105817000.00
PRCT cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 6090000.00
PRCT balance_sheet (annual, 2023-12-31) — Properties: 0.00
PRCT cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
PRCT cash_flow (annual, 2023-12-31) — Purchase Of PPE: -25206000.00
PRCT balance_sheet (annual, 2023-12-31) — Raw Materials: 11832000.00
PRCT balance_sheet (annual, 2023-12-31) — Receivables: 48376000.00
PRCT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 65142000.00
PRCT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 3807000.00
PRCT cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
PRCT income_statement (annual, 2023-12-31) — Research And Development: 48446000.00
PRCT balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
PRCT balance_sheet (annual, 2023-12-31) — Retained Earnings: -454572000.00
PRCT income_statement (annual, 2023-12-31) — Selling General And Administration: 131773000.00
PRCT balance_sheet (annual, 2023-12-31) — Share Issued: 50771000.00
PRCT income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
PRCT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 19134000.00
PRCT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 280752000.00
PRCT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 279548000.00
PRCT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
PRCT income_statement (annual, 2023-12-31) — Tax Provision: 80000.00
PRCT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
PRCT balance_sheet (annual, 2023-12-31) — Total Assets: 404717000.00
PRCT balance_sheet (annual, 2023-12-31) — Total Capitalization: 332091000.00
PRCT balance_sheet (annual, 2023-12-31) — Total Debt: 79204000.00
PRCT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 280752000.00
PRCT income_statement (annual, 2023-12-31) — Total Expenses: 245361000.00
PRCT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 123965000.00
PRCT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 54150000.00
PRCT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 78038000.00
PRCT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -109170000.00
PRCT balance_sheet (annual, 2023-12-31) — Total Tax Payable: 1725000.00
PRCT income_statement (annual, 2023-12-31) — Total Unusual Items: -107000.00
PRCT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -107000.00
PRCT balance_sheet (annual, 2023-12-31) — Work In Process: 6047000.00
PRCT balance_sheet (annual, 2023-12-31) — Working Capital: 304640000.00
PRCT cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: 58000.00
PRCT cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 58000.00
PRCT income_statement (annual, 2024-12-31) — +Operating Expense: 233713000.00
PRCT income_statement (annual, 2024-12-31) — +Total Revenue: 224498000.00
PRCT balance_sheet (annual, 2024-12-31) — Accounts Payable: 10032000.00
PRCT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 83496000.00
PRCT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -7830000.00
PRCT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 948091000.00
PRCT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1881000.00
PRCT income_statement (annual, 2024-12-31) — Basic Average Shares: 52125000.00
PRCT income_statement (annual, 2024-12-31) — Basic EPS: -1.75
PRCT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 260260000.00
PRCT cash_flow (annual, 2024-12-31) — Capital Expenditure: -4409000.00
PRCT balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 28778000.00
PRCT balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
PRCT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 333725000.00
PRCT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 333725000.00
PRCT balance_sheet (annual, 2024-12-31) — Cash Equivalents: 322764000.00
PRCT balance_sheet (annual, 2024-12-31) — Cash Financial: 10961000.00
PRCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 180125000.00
PRCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -4409000.00
PRCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -99213000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Account Payable: -2152000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 4786000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Interest Payable: 134000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Inventory: -17235000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -1637000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 1771000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 6312000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Payable: -2152000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2634000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -3211000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Receivables: -35960000.00
PRCT cash_flow (annual, 2024-12-31) — Change In Working Capital: -47326000.00
PRCT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -35960000.00
PRCT cash_flow (annual, 2024-12-31) — Changes In Cash: 76503000.00
PRCT balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
PRCT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 402220000.00
PRCT cash_flow (annual, 2024-12-31) — Common Stock Issuance: 164523000.00
PRCT cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 164523000.00
PRCT balance_sheet (annual, 2024-12-31) — Construction In Progress: 262000.00
PRCT income_statement (annual, 2024-12-31) — Cost Of Revenue: 87399000.00
PRCT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1065000.00
PRCT balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 1065000.00
PRCT balance_sheet (annual, 2024-12-31) — Current Assets: 481842000.00
PRCT balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1910000.00
PRCT balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1910000.00
PRCT balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 9565000.00
PRCT balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 9565000.00
PRCT balance_sheet (annual, 2024-12-31) — Current Liabilities: 53133000.00
PRCT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 5234000.00
PRCT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 5234000.00
PRCT income_statement (annual, 2024-12-31) — Diluted Average Shares: 52125000.00
PRCT income_statement (annual, 2024-12-31) — Diluted EPS: -1.75
PRCT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -91413000.00
PRCT income_statement (annual, 2024-12-31) — EBIT: -86861000.00
PRCT income_statement (annual, 2024-12-31) — EBITDA: -81627000.00
PRCT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
PRCT cash_flow (annual, 2024-12-31) — End Cash Position: 336763000.00
PRCT cash_flow (annual, 2024-12-31) — Financing Cash Flow: 180125000.00
PRCT balance_sheet (annual, 2024-12-31) — Finished Goods: 26527000.00
PRCT cash_flow (annual, 2024-12-31) — Free Cash Flow: -103622000.00
PRCT cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 114000.00
PRCT cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 0.00
PRCT income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -114000.00
PRCT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 114000.00
PRCT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 932000.00
PRCT balance_sheet (annual, 2024-12-31) — Gross PPE: 53480000.00
PRCT income_statement (annual, 2024-12-31) — Gross Profit: 137099000.00
PRCT income_statement (annual, 2024-12-31) — Interest Expense: 4184000.00
PRCT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 4184000.00
PRCT income_statement (annual, 2024-12-31) — Interest Income: 10895000.00
PRCT income_statement (annual, 2024-12-31) — Interest Income Non Operating: 10895000.00
PRCT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 3970000.00
PRCT balance_sheet (annual, 2024-12-31) — Interest Payable: 310000.00
PRCT balance_sheet (quarterly, 2024-12-31) — Interest Payable: 310000.00
PRCT balance_sheet (annual, 2024-12-31) — Inventory: 56168000.00
PRCT balance_sheet (annual, 2024-12-31) — Invested Capital: 453692000.00
PRCT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -4409000.00
PRCT cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 164523000.00
PRCT cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 164523000.00
PRCT cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
PRCT balance_sheet (annual, 2024-12-31) — Leases: 12488000.00
PRCT balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 26868000.00
PRCT balance_sheet (annual, 2024-12-31) — Long Term Debt: 51472000.00
PRCT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 78340000.00
PRCT cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
PRCT cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
PRCT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 19683000.00
PRCT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 164523000.00
PRCT cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 164523000.00
PRCT cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PRCT income_statement (annual, 2024-12-31) — Net Income: -91413000.00
PRCT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -91413000.00
PRCT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -91413000.00
PRCT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -91413000.00
PRCT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -91413000.00
PRCT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -91413000.00
PRCT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -91413000.00
PRCT income_statement (annual, 2024-12-31) — Net Interest Income: 6711000.00
PRCT cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
PRCT cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
PRCT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 6711000.00
PRCT balance_sheet (annual, 2024-12-31) — Net PPE: 45650000.00
PRCT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -4409000.00
PRCT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 401288000.00
PRCT income_statement (annual, 2024-12-31) — Normalized EBITDA: -81513000.00
PRCT income_statement (annual, 2024-12-31) — Normalized Income: -91299000.00
PRCT cash_flow (annual, 2024-12-31) — Operating Cash Flow: -99213000.00
PRCT cash_flow (annual, 2024-12-31) — Operating Gains Losses: 114000.00
PRCT cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 0.00
PRCT income_statement (annual, 2024-12-31) — Operating Income: -96614000.00
PRCT income_statement (annual, 2024-12-31) — Operating Revenue: 224498000.00
PRCT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 54718000.00
PRCT balance_sheet (annual, 2024-12-31) — Other Current Assets: 8453000.00
PRCT balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 6956000.00
PRCT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 114000.00
PRCT income_statement (annual, 2024-12-31) — Other Income Expense: -1142000.00
PRCT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 932000.00
PRCT balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 932000.00
PRCT cash_flow (annual, 2024-12-31) — Other Non Cash Items: -383000.00
PRCT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 5593000.00
PRCT balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 324000.00
PRCT income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -1028000.00
PRCT balance_sheet (annual, 2024-12-31) — Other Properties: 21047000.00
PRCT balance_sheet (annual, 2024-12-31) — Payables: 12100000.00
PRCT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 13165000.00
PRCT balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 21537000.00
PRCT balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
PRCT income_statement (annual, 2024-12-31) — Pretax Income: -91045000.00
PRCT cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 15602000.00
PRCT balance_sheet (annual, 2024-12-31) — Properties: 0.00
PRCT cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 840000.00
PRCT cash_flow (annual, 2024-12-31) — Purchase Of PPE: -4409000.00
PRCT balance_sheet (annual, 2024-12-31) — Raw Materials: 18189000.00
PRCT balance_sheet (annual, 2024-12-31) — Receivables: 83496000.00
PRCT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 87399000.00
PRCT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 5234000.00
PRCT cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
PRCT income_statement (annual, 2024-12-31) — Research And Development: 62298000.00
PRCT balance_sheet (annual, 2024-12-31) — Retained Earnings: -545985000.00
PRCT income_statement (annual, 2024-12-31) — Selling General And Administration: 171415000.00
PRCT balance_sheet (annual, 2024-12-31) — Share Issued: 54718000.00
PRCT income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
PRCT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 31840000.00
PRCT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 402220000.00
PRCT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 401288000.00
PRCT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
PRCT income_statement (annual, 2024-12-31) — Tax Provision: 368000.00
PRCT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
PRCT balance_sheet (annual, 2024-12-31) — Total Assets: 534017000.00
PRCT balance_sheet (annual, 2024-12-31) — Total Capitalization: 453692000.00
PRCT balance_sheet (annual, 2024-12-31) — Total Debt: 80250000.00
PRCT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 402220000.00
PRCT income_statement (annual, 2024-12-31) — Total Expenses: 321112000.00
PRCT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 131797000.00
PRCT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 52175000.00
PRCT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 78664000.00
PRCT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -96614000.00
PRCT balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2068000.00
PRCT balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 2068000.00
PRCT income_statement (annual, 2024-12-31) — Total Unusual Items: -114000.00
PRCT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -114000.00
PRCT balance_sheet (annual, 2024-12-31) — Work In Process: 11452000.00
PRCT balance_sheet (annual, 2024-12-31) — Working Capital: 428709000.00
PRCT income_statement (quarterly, 2025-03-31) — +Operating Expense: 71599000.00
PRCT income_statement (quarterly, 2025-03-31) — +Total Revenue: 69162000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 14827000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 79267000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -9177000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 959656000.00
PRCT cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 330000.00
PRCT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 54917000.00
PRCT income_statement (quarterly, 2025-03-31) — Basic EPS: -0.45
PRCT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 336763000.00
PRCT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1836000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 28315000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
PRCT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 316207000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 316207000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 304549000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Cash Financial: 11658000.00
PRCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1298000.00
PRCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1836000.00
PRCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -16980000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 3754000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -6536000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Interest Payable: 25000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Inventory: -6282000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -395000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 390000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 235000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Payable: 3754000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2782000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 576000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3929000.00
PRCT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -4329000.00
PRCT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 3929000.00
PRCT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -17518000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
PRCT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 389157000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1498000.00
PRCT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 25001000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Current Assets: 465791000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1983000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Current Debt: 2000000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3983000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 9799000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 9799000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 52064000.00
PRCT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1475000.00
PRCT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1475000.00
PRCT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 54917000.00
PRCT income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.45
PRCT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -24737000.00
PRCT income_statement (quarterly, 2025-03-31) — EBIT: -23907000.00
PRCT income_statement (quarterly, 2025-03-31) — EBITDA: -22432000.00
PRCT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
PRCT cash_flow (quarterly, 2025-03-31) — End Cash Position: 319245000.00
PRCT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1298000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Finished Goods: 32233000.00
PRCT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -18816000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 223000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 864000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 55909000.00
PRCT income_statement (quarterly, 2025-03-31) — Gross Profit: 44161000.00
PRCT income_statement (quarterly, 2025-03-31) — Interest Expense: 877000.00
PRCT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 877000.00
PRCT income_statement (quarterly, 2025-03-31) — Interest Income: 3531000.00
PRCT income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3531000.00
PRCT cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 885000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Inventory: 62330000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 442655000.00
PRCT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1836000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Leases: 12488000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 2000000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 26332000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 51498000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 77830000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 20660000.00
PRCT cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PRCT income_statement (quarterly, 2025-03-31) — Net Income: -24737000.00
PRCT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -24737000.00
PRCT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -24737000.00
PRCT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -24737000.00
PRCT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -24737000.00
PRCT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -24737000.00
PRCT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -24737000.00
PRCT income_statement (quarterly, 2025-03-31) — Net Interest Income: 2654000.00
PRCT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 2654000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Net PPE: 46732000.00
PRCT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1836000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 388293000.00
PRCT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -22432000.00
PRCT income_statement (quarterly, 2025-03-31) — Normalized Income: -24737000.00
PRCT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -16980000.00
PRCT income_statement (quarterly, 2025-03-31) — Operating Income: -27438000.00
PRCT income_statement (quarterly, 2025-03-31) — Operating Revenue: 69162000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 55278000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 7987000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 8479000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 223000.00
PRCT cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -127000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5988000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 324000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Other Properties: 21263000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Payables: 14827000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 14827000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 14976000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
PRCT income_statement (quarterly, 2025-03-31) — Pretax Income: -24784000.00
PRCT cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 1298000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PRCT cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 300000.00
PRCT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1836000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Raw Materials: 19199000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Receivables: 79267000.00
PRCT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 25001000.00
PRCT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1475000.00
PRCT income_statement (quarterly, 2025-03-31) — Research And Development: 16402000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -570722000.00
PRCT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 55197000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Share Issued: 55278000.00
PRCT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 10108000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 389157000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 388293000.00
PRCT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PRCT income_statement (quarterly, 2025-03-31) — Tax Provision: -47000.00
PRCT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
PRCT balance_sheet (quarterly, 2025-03-31) — Total Assets: 519375000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 440655000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Total Debt: 81813000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 389157000.00
PRCT income_statement (quarterly, 2025-03-31) — Total Expenses: 96600000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 130218000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 53584000.00